Publications
National Hospital Cost Data Collection Private Hospital Report 2018–19
The private sector National Hospital Cost Data Collection (NHCDC) is a voluntary collection that produces a range of hospital cost and activity information by the Australian Refined Diagnosis Related Groups (AR-DRG). This report includes the findings from (financial yea...
Aged Care Pricing Commissioner Annual Report 2019-20
The Annual Report of the Aged Care Pricing Commissioner covers the Commissioner’s operations for the year 1 July 2019 to 30 June 2020 in accordance with Section 95B-12 of the Aged Care Act 1997.
IHPA Annual Report 2019–20
The Independent Hospital Pricing Authority (IHPA) Annual Report for financial year 2019–20.
Emergency department care FAQs – Part 2 (Published 17 September 2020)
FAQs to support the classification of COVID-19 in emergency department care.
Consultation and review of the AR-DRG and ICD-10-AM/ACHI/ACS Classification Systems
The development cycle of the admitted care classifications was last reviewed in 2009. Since that time the landscape has changed significantly with the National Health Reform Agreement in 2011 and the introduction of activity based funding nationally. The recent review f...
COVID-19 Response - Costing and Pricing Guidelines
This document guides costing practitioners on the steps to capturing end-to-end COVID-19 activity and expenses under the National Partnership Agreement (NPA). It identifies the principles to be applied, the scope of activity and costs to be funded, cost allocation metho...
IHPA Work Program 2020–21
The Independent Hospital Pricing Authority Work Program has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011.
Chimeric antigen receptor T cell therapy (CAR-T cell) - guidelines for costing, counting and reconciliation of funding
The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults...
Impact of New Health Technology Framework Version 4.4
IHPA recognises the need for the pricing of public hospital services to respond in a timely manner to the introduction of new health technologies and innovations in models of care.